Core Viewpoint - The company, Dahu Co., is experiencing a decline in revenue and profitability across its main business segments, including aquaculture, liquor, and healthcare, leading to a challenging financial outlook [1]. Group 1: Financial Performance - As of July 29, 2025, Dahu Co.'s stock price is 5.46 yuan, down 0.04 yuan or 0.73% from the previous trading day, with a trading volume of 126,748 hands and a turnover of 0.69 billion yuan [1]. - In the first half of the year, the company's operating revenue was 426 million yuan, a year-on-year decrease of 14.4%, with a net profit loss of 2.57 million yuan [1]. - The healthcare segment's revenue from the Changzhou Sunshine Rehabilitation Hospital fell by 42.97% year-on-year due to policy adjustments, while the liquor business revenue was 40.2 million yuan, down 17% [1]. Group 2: Business Segments - Dahu Co. operates in three main business areas: aquaculture, liquor, and healthcare, with 168,000 acres of freshwater farming resources, primarily producing organic freshwater fish and Yangcheng Lake hairy crabs [1]. - The liquor business is centered around the "Deshan" brand, covering three major flavor types: sauce, strong, and mixed [1]. - The healthcare segment is involved in rehabilitation medical services through its subsidiary, Dongfang Huakang [1]. Group 3: Inventory and Operational Challenges - The company's inventory balance reached 446 million yuan, with consumable biological assets accounting for 63.7% of the total [1]. - The inventory turnover rate has worsened to 0.71 times, indicating increased pressure on inventory management [1].
大湖股份股价微跌0.73% 医疗业务拖累上半年亏损257万元